Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finlay A Macrae

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Gut|January 8, 2021
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriersPeter Georgeson, Bernard J Pope, Christophe Rosty, et al.
Familial Cancer|July 24, 2015
Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair geneAung Ko Win, Jeanette C Reece, Daniel D Buchanan, et al.
British Journal of Cancer|September 26, 2019
Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndromeS Ghazaleh Dashti, Wing Yan Li, Daniel D Buchanan, et al.
Gut|January 4, 2011
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgerySusan Parry, Aung Ko Win, Bryan Parry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2016
Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation CarriersS Ghazaleh Dashti, Daniel D Buchanan, Harindra Jayasekara, et al.
Journal of the National Cancer Institute|August 31, 2012
Risks of primary extracolonic cancers following colorectal cancer in lynch syndromeAung Ko Win, Noralane M Lindor, Joanne P Young, et al.
JNCI Cancer Spectrum|December 14, 2024
Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial riskRobert J MacInnis, Mark A Jenkins, Roger L Milne, et al.
Journal of Crohn'S & Colitis|February 1, 2018
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's DiseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Journal of the National Cancer Institute|June 26, 2015
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch SyndromeDriss Ait Ouakrim, Seyedeh Ghazaleh Dashti, Rowena Chau, et al.
The Journal of Molecular Diagnostics : JMD|November 17, 2022
Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair StatusRomy Walker, Peter Georgeson, Khalid Mahmood, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Gut|January 8, 2021
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriersPeter Georgeson, Bernard J Pope, Christophe Rosty, et al.
Familial Cancer|July 24, 2015
Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair geneAung Ko Win, Jeanette C Reece, Daniel D Buchanan, et al.
British Journal of Cancer|September 26, 2019
Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndromeS Ghazaleh Dashti, Wing Yan Li, Daniel D Buchanan, et al.
Gut|January 4, 2011
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgerySusan Parry, Aung Ko Win, Bryan Parry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 5, 2016
Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation CarriersS Ghazaleh Dashti, Daniel D Buchanan, Harindra Jayasekara, et al.
Journal of the National Cancer Institute|August 31, 2012
Risks of primary extracolonic cancers following colorectal cancer in lynch syndromeAung Ko Win, Noralane M Lindor, Joanne P Young, et al.
JNCI Cancer Spectrum|December 14, 2024
Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial riskRobert J MacInnis, Mark A Jenkins, Roger L Milne, et al.
Journal of Crohn'S & Colitis|February 1, 2018
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's DiseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Journal of the National Cancer Institute|June 26, 2015
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch SyndromeDriss Ait Ouakrim, Seyedeh Ghazaleh Dashti, Rowena Chau, et al.
The Journal of Molecular Diagnostics : JMD|November 17, 2022
Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair StatusRomy Walker, Peter Georgeson, Khalid Mahmood, et al.
Pageof 12